Laxminarayan Bhat
2022
In 2022, Laxminarayan Bhat earned a total compensation of $560K as Chief Executive Officer and President at REVIVA PHARMACEUTICALS HOLDINGS, a 7% decrease compared to previous year.
Compensation breakdown
| Bonus | $160,000 |
|---|---|
| Salary | $400,000 |
| Total | $560,000 |
Bhat received $400K in salary, accounting for 71% of the total pay in 2022.
Bhat also received $160K in bonus.
Rankings
In 2022, Laxminarayan Bhat's compensation ranked 4,148th out of 5,669 executives tracked by ExecPay. In other words, Bhat earned more than 26.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,148 out of 5,669 | 27th |
Division Manufacturing | 2,342 out of 3,081 | 24th |
Major group Chemicals And Allied Products | 1,141 out of 1,396 | 18th |
Industry group Drugs | 1,071 out of 1,297 | 17th |
Industry Pharmaceutical Preparations | 779 out of 940 | 17th |
Source: SEC filing on October 4, 2023.
Bhat's colleagues
We found two more compensation records of executives who worked with Laxminarayan Bhat at REVIVA PHARMACEUTICALS HOLDINGS in 2022.